The company announced the 50 per cent acquisition of Mumbai-based Sterling Biotech Ltd. Zydus will be taking over Sterling Biotech's API or Active Pharmaceutical Ingredients Business. Zydus Makes ...

Michael Gilman, biotech entrepreneur: I am — as a parent and grandparent, rather than a life science executive — considerably ...

A Dallas-based biotech company has nearly completed its reconstruction of the Tasmanian tiger just two years into its de-extinction project. The last known thylacine, commonly referred to as the ...

Sterling Bay is looking to offload a biotech property on Chicago’s North Side, as its life sciences real estate holdings and its Lincoln Yards project face setbacks. The Chicago-based firm ...

Lincoln Yards developer Sterling Bay plans to sell the biotech center near the North Side development as it faces challenges in the biosciences sector and its own plans for the area. The Lincoln ...

Bright Minds Biosciences, which until this week had a lightly traded stock that traded at just over $1, tumbled in premarket trade on Wednesday following a meteoric rise. Bright Minds shares DRUG ...

A great performance over the last 12 months has pushed our writer to buy more of a very exciting investment trust for his Stocks and Shares ISA. Paul Summers explains why.

Hello! Hope you had a restful and reflective Indigenous Peoples’ Day. Today, we talk about how the autoimmune disease space is hotter than ever, see more gene therapy contraction, and the CEO of ...

It has been a decent year for the biotech industry so far, buoyed by new drug approvals and positive regulatory/pipeline updates. The third-quarter earnings season has just kicked off, with most ...

SyVento says bringing the FlexFactory to Poland makes new therapies available to patients in an efficient and high-quality way.

Biotech stocks are in the eye of the storm as the world recovers from the global pandemic. Government institutions and professional traders are banking on biotech stocks to continually develop a ...

SOMERSET, N.J., Nov. 04, 2024 (GLOBE NEWSWIRE) -- Legend Biotech Corporation (NASDAQ: LEGN) (Legend Biotech), a global leader in cell therapy, today announced the appointment of Alan Bash as the ...